Refining the role of PARP inhibitors in targeted anticancer therapy

Share :
Published: 11 Mar 2015
Views: 4633
Rating:
Save
Prof Yves Pommier - National Cancer Institute, Bethesda, USA

Prof Pommier talks to ecancertv at TAT 2015 about the role of PARP inhibitors in targeted anticancer therapies - particularly in combination with other therapeutic agents, including DNA-targeting drugs.